Presentations

Graham C, Lewis J, Bronstone A, Hankin CS. Decision analytic model comparing real-time continuous glucose monitoring plus self-monitoring of blood glucose versus self-monitoring of blood glucose alone on high-cost short-term acute diabetes complications requiring hospitalization. Poster presented at the AMCP 2013 Nexus: Connecting Healthcare and Innovation. October 13-15, 2013; San Antonio, TX.

Buck PO, Buatti Small M, Hankin CS, Bronstone A, Wang Z, Gopalan GH, Lepore MS. Asthma-related health care utilization in patients with oral corticosteroid-dependent asthma. Poster presented at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. May 18-22, 2013; New Orleans, LA.

Hankin CS, Bronstone A, Wang Z, Buatti-Small M; Buck PO. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. Podium presentation at the 2013 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. February 22-26, 2013; San Antonio, TX.

Peters SP, Benninger MS, Hankin CS, Wang Z, Bronstone A, Buck PO, Lepore MS. Incidence of oral candidiasis among patients with asthma receiving fluticasone propionate/salmeterol dry powder inhaler versus extra-fine beclomethasone dipropionate hydrofluoroakane: large-scale retrospective claims analysis. Poster presented at the 2013 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. February 22-26, 2013; San Antonio, TX.

Buck PO, Hankin CS; Cox L, Bronstone A, Wang Z, Lepore MS. Satisfactory adherence to intranasal corticosteroids is associated with significantly reduced number and costs of outpatient visits among patients newly diagnosed with allergic rhinitis. Podium presentation at the 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research. November 3-7, 2012; Berlin, Germany.

Hankin CS, Cox L, Bronstone A, Wang Z, Buck PO, Lepore M. Reduced likelihood of multiple hospitalizations in patients newly diagnosed with allergic rhinitis who receive intranasal corticosteroids. Poster presented at the 2012 Annual Meeting of the American College of Allergy, Asthma & Immunology November 8-13, 2012; Anaheim, CA.

Buck PO, Cox L, Lang D, Hankin CS, Wang Z, Bronstone A, Lepore M. Comparison of health outcomes of patients with allergic rhinitis receiving pressurized metered-dose inhaler versus aqueous intranasal corticosteroid formulations. Poster presented at the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. March 2-6, 2012; Orlando, FL.

Lepore M, Lang D, Cox L, Hankin CS, Wang Z, Bronstone A, Buck PO. Comparison of patient adherence to intranasal corticosteroids by pressurized metered-dose inhaler versus aqueous formulations. Poster presented at the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. March 2-6, 2012; Orlando, FL.

Hankin CS, Cox L, Bronstone A, Wang Z. Poor concordance between patient-reported and physician-assumed reasons underlying patient adherence to allergen-specific immunotherapy. Poster presentation at the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. March 2-6, 2012; Orlando, FL.

Hankin CS, Cox L, Bronstone A, Wang Z. Does allergen-specific immunotherapy reduce the risk, reverse and/or mitigate asthma in children with allergic rhinitis: The Pediatric IMproved Access to AllerGEN-specific ImmunNothErapy − asthma incidence rates among Medicaid enrollees (Pediatric IMAGINE-AIRE) study, funded by the Joint Council of Allergy, Asthma and Immunology. Poster presented at the 2012 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. March 2-6, 2012; Orlando, FL.

Hankin CS, Cox L, Wang Z, Bronstone A. Comorbid allergy-related respiratory conditions among children and adults diagnosed with allergic rhinitis: findings from research jointly funded by the AAAAI and ACAAI. Poster presented at the 2011 World Allergy Congress. December 4-8, 2011; Cancun, Mexico.

Hankin CS, Cox L, Wang Z, Bronstone A. Initiation and adherence to de novo allergen-specific immunotherapy among adults and children with newly-diagnosed allergic rhinitis: findings from research jointly funded by the AAAAI and ACAAI. Oral presentation at the 2011 World Allergy Congress. December 4-8, 2011; Cancun, Mexico.

Hankin CS, Cox L, Wang Z, Bronstone A. Does allergen-specific immunotherapy provide cost benefits for children and adults with allergic rhinitis? Results from large-scale retrospective analyses jointly funded by AAAAI and ACAAI. Oral presentation at the 2011 Annual Conference of the American Academy of Allergy, Asthma & Immunology; March 18-22, 2011; San Francisco, CA.

Hankin CS, Wang Z, Cox L, Bronstone A. Allergen immunotherapy significantly reduces healthcare costs among U.S. adults with allergic rhinitis: A retrospective matched cohort study jointly funded by the AAAAI and ACAAI. Poster presented at the 2011 Annual Conference of the American Academy of Allergy, Asthma & Immunology; March 18-22, 2011; San Francisco, CA.

Hankin CS, Kelechi TJ, Mueller M, Bronstone A. Efficacy and safety of poly-N-acetyl-glucosamine, nanofiber-derived advanced wound healing technology (pGlcNAc) for treatment of patients with venous leg ulcers: a randomized, controlled, investigator-blinded pilot study. Poster presented at the 10th Clinical Meeting of the American Professional Wound Care Association. March 31-April 3, 2011; Philadelphia, PA.

Kelechi T, Mueller, M, Hankin C, Bronstone A, Samies J, Bonham P. Safety and efficacy trial of a new membrane (pGlcNAc) in patients with venous leg ulcers. Poster presented at the 43rd Annual Conference of the Wound, Ostomy and Continence Nurses Society. June 4-8, 2011; New Orleans, LA.

Hankin CS, Norris MM, Bronstone A. Estimated United States incidence and cost of emergency department staff assaults perpetrated by agitated adult patients with schizophrenia or bipolar disorder. Poster presented at the 15th International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Atlanta, GA; May 15-19, 2010.

Hankin CS, Bronstone A, Zun L. Estimated United States incidence of physical assaults perpetrated by agitated adult patients with schizophrenia or bipolar disorder on nurses and physicians in the general emergency department. Poster presented at the American Society for Health-System Pharmacists 2010 Summer Meeting. Tampa, FL; June 6-9, 2010.

Hankin CS, Bronstone A, Troupin B. Ten percent or greater weight loss is a clinically meaningful outcome in the treatment of obesity. Poster presented at the 32nd Annual Meeting of the Society for Medical Decision Making. Toronto, Ontario; October 24-27, 2010.

Hankin CS, Lebwohl M, Burgoyne D, Dunn J, Gleeson J, Knispel J, Lopes M, Bronstone A, Wang Z. Patient characteristics and patterns of care in the pharmacologic treatment of moderate-to-severe psoriasis. Poster presented at the Summer Academy Meeting 2009 of the American Academy of Dermatology; July 29-Aug 2, 2009; San Francisco, CA.

Hankin CS, Gleeson J, Burgoyne D, Dunn J, Knispel J, Lopes M, Bronstone A. Comparative and cost effectiveness of treatments for moderate-to-severe psoriasis. Poster presented at the Academy of Managed Care Pharmacy 21st Annual Meeting and Showcase. Orlando, FL; April 15-28, 2009.

Hankin CS, Dunn JD, Knispel J, Levin A, Bronstone A, Wang Z. Adequacy of SSRI Pharmacotherapy among Medicaid-enrolled Patients Newly-diagnosed with Obsessive-Compulsive Disorder. Poster presented at the 2008 Annual Meeting of the American Psychiatric Association; May 3-8, 2008; Washington, D.C.

Hankin C, Koran LM, Culpepper L, Knispel J, Dougherty D, Hollander E, Sheehan DV, Dunn JD, Black DW, Bronstone A, Wang Z. Comparison of healthcare use and costs of adult patients with "pure obsessive-compulsive disorder" versus "pure depression": nine-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid enrollees. Poster presented at the 31st Annual Society of General Internal Medicine Annual Meeting; April 9-12, 2008; Pittsburgh, PA.

Hankin C, Koran LM, Culpepper L, Knispel J, Dougherty D, Hollander E, Sheehan DV, Dunn JD, Black DW, Bronstone A, Wang Z. Comparison of healthcare use and costs of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”: nine-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid enrollees. Poster presented at the 2008 California/Hawaii Regional Meeting of the Society for General Internal Medicine. San Francisco, CA; March 1, 2008.

Hankin C, Knispel J, Dunn JD, Levin A, Cullpepper L, Dougherty D, Koran L, Hollander E, Sheehan D, Black D, Bronstone A, Wang Z. Health care use and costs of patients with "pure obssesive-compulsive disorder" versus "pure depression": 9-year (1997-2006), large-scale, retrospective claims analysis of Florida Medicaid adults enrollees. Poster presented at the 13th International Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 3-7, 2008; Toronto, Ontario, Canada.

Hankin C, Cox L, Lang D, Gross G, Fass P, Leatherman B, Bronstone A, Wang S. Does allergy immunotherapy confer healthcare cost benefits for children with allergic rhinitis? A large-scale, retrospective, claims-based study. Podium presentation at the American College of Allergy, Asthma, and Immunology 2008 Annual Meeting; Seattle, WA; November 6-11, 2008.

Hankin C, Koran LM, Culpepper L, Dunn JD, Black DW, Hollander E, Knispel J, Wang Z, Bronstone A, Dougherty DD, Levin A. Patients with “pure OCD” incur higher 2-year psychotropic costs than patients with “pure depression.” Poster presented at the 21st European College of Neuropsychopharmacology Congress; August 30-September 3, 2008, Barcelona, Spain.

Hankin CS, Dunn J, Knispel J, Levin A, Wang Z, Bronstone A. Comparison of healthcare burden of adult patients with “pure obsessive-compulsive disorder” versus “pure depression”: nine-year claims analysis of Florida Medicaid enrollees. Poster presented at the Academy of Managed Care Pharmacy 2008 Educational Conference. Kansas City, MO; October 15-17, 2008.

Hankin CS, Cox L, Wang Z, Bronstone A. Allergy immunotherapy practice patterns and associated outcomes of care. Oral Presentation at the Annual Meeting of the American Academy for Allergy, Asthma and Immunology; San Diego, CA; February 23-26, 2007.
Hankin CS, Bordeaux M, Bronstone A. Sublingual immunotherapy (SLIT) in the U.S. Podium Presentation at the 63rd American Academy of Allergy, Asthma, and Immunology Annual Meeting, RSOD Interest Section Forum. San Diego, CA; February 25, 2007.

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation at the 12th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Arlington, VA; May 22, 2007.

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation at the Florida Allergy, Asthma, and Immunology Society’s 2007 Annual Meeting, Sarasota, FL; June 10, 2007.

Hankin C, Cox L, Lang D, Levin A, Gross G, Eavy G, Meltzer E, Burgoyne D, Bronstone A, Wang Z. Allergy immunotherapy among Medicaid-enrolled children with rhinitis: patterns of care, resource use, and costs. Podium presentation at the 134th American Public Health Association Annual Meeting. Washington, D.C.; November 3-7, 2007.

Hankin C, Cox L, Lang D, Gross G, Fass P, Leatherman B, Bronstone A, Wang S. Does allergy immunotherapy confer healthcare cost benefits for children with allergic rhinitis? A large-scale, retrospective, claims-based study. Podium presentation at the American College of Allergy, Asthma & Immunology 2008 Annual Meeting; Seattle, WA; November 6-11, 2008.

Hankin CS, Wang Z, Bronstone A. Adherence to monthly injectable leuprolide acetate among Florida Medicaid-enrolled children with central precocious puberty. Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2-6, 2007; Las Vegas, NV.

Hankin CS, Silverman L, Wang Z, Bronstone A. Association between central precocious puberty and psychiatric disorders: large-scale retrospective claims analysis of Florida Medicaid-enrolled children. Poster presented at the 29th Annual Meeting of the Society for Medical Decision Making; October 21-24, 2007; Pittsburgh, PA.

Hankin C, Fish L, Dunn JD, Fenrick R, Bronstone A, Wang Z. Likelihood of initiating antilipidemics by patient sex, race/ethnicity, age and comorbidity. Poster presented at the 10th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Dublin, Ireland; October 2007.

Hankin C, Dunn JD, Fenrick R, Fish L, Wang Z, Bronstone A. Persistence to antilipidemics varies by sex, age, and race/ethnicity: analysis of a large-scale, retrospective claims database. Poster presented at the 10th European Congress of the International Society for Pharmacoeconomics and Outcomes Research. Dublin, Ireland; October 20-23, 2007.

Hankin CS, Brener B, Wu J, Wang Z, Bronstone A. Disparity in response to metformin among obese versus non-obese patients with type 2 diabetes. Poster presented at the 1st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy). Berlin, Germany; October 2006.

Hankin CS, Wang Z, Bronstone A, Brener B, Wu J. Role of gender on response to anti-hyperglycemic medication. Poster presented at the American Society of Health-System Pharmacists 41st Midyear Annual Clinical Meeting. Anaheim, CA; December 2006.

Hankin CS, Berner B, Wu J, Bronstone A, Wang Z. Comparison of treatment persistence with two formulations of metformin. Poster presented at the 28th Annual Meeting of the Society for Medical Decision Making. Boston, MA; October 2006.